Concepedia

Xiaoyue Bi

XB

Statistics

Publications

10

Citations

177

H-Index

10

Active since

2015

Affiliations

Peking University(Current)

Beijing Ditan Hospital

Capital Medical University

Beijing Tsinghua Chang Gung Hospital

Tsinghua University

Xiaoyue Bi is an author at Peking University specializing in hepatitis pharmacotherapy, viral hepatitis treatment, and liver disease.

ORCID

Publications per year

2015–2023

10

Publications

10

The WNT/β-catenin signaling pathway may be involved in granulosa cell apoptosis from patients with PCOS in North China

Xueqing Wu, Y.-q. Wang, Sujuan Xu et al. · Journal of Gynecology Obstetrics and Human Reproduction · 2015 · 42 citations

, , +14

Consolidation treatment needed for sustained HBsAg-negative response induced by interferon-alpha in HBeAg positive chronic hepatitis B patients

Minghui Li, Fangfang Sun, Xiaoyue Bi et al. · Virologica Sinica · 2022 · 28 citations · Full text

, , +16

Dynamic Changes of Cytokine Profiles and Virological Markers Associated With HBsAg Loss During Peginterferon Alpha-2a Treatment in HBeAg-Positive Chronic Hepatitis B Patients

Minghui Li, Luxue Zhang, Si Xie et al. · Frontiers in Immunology · 2022 · 18 citations · Full text

, , +17

Efficacy and Safety of Glycyrrhizic Acid in Treatment of Autoimmune Hepatitis

Xiaoyue Bi, Liu Yang, Yanjie Lin et al. · The American Journal of Chinese Medicine · 2023 · 18 citations

, , +13

An optimized mode of interferon intermittent therapy help improve HBsAg disappearance in chronic hepatitis B patients

Minghui Li, Si Xie, Xiaoyue Bi et al. · Frontiers in Microbiology · 2022 · 13 citations · Full text

, , +17

1–5 of 10